SOCs commonly implicated in adverse event signaling for oseltamivir and baloxavir marboxil include gastrointestinal disorders, general disorders and administration site conditions, skin and subcutaneous tissue disorders, and psychiatric disorders (Figure 3 illustrates the signal strength of the ROR). This evidence concerns the gene CISH and digestive system disorder.